Literature DB >> 10446853

ACR 20: clinical or statistical significance?

T Pincus1, C M Stein.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10446853     DOI: 10.1002/1529-0131(199908)42:8<1572::AID-ANR2>3.0.CO;2-G

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  11 in total

Review 1.  Clinical outcome measures in rheumatoid arthritis.

Authors:  P L van Riel; A M van Gestel
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  What will treatment of autoimmune diseases entail in 2010?

Authors:  T W Huizinga; F C Breedveld
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.

Authors:  Christine M Nguyen; Mark Bounthavong; Margaret A S Mendes; Melissa L D Christopher; Josephine N Tran; Rashid Kazerooni; Anthony P Morreale
Journal:  Pharmacoeconomics       Date:  2012-07-01       Impact factor: 4.981

Review 4.  Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.

Authors:  C P Chung; J L Thompson; G G Koch; I Amara; V Strand; T Pincus
Journal:  Ann Rheum Dis       Date:  2006-02-27       Impact factor: 19.103

Review 5.  WITHDRAWN: Celecoxib for rheumatoid arthritis.

Authors:  Sarah E Garner; Dogan Fidan; Ruth R Frankish; Maria Judd; Beverley Shea; Tanveer Towheed; Peter Tugwell; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2017-06-09

6.  Brief report: rheumatoid arthritis response criteria and patient-reported improvement in arthritis activity: is an American College of Rheumatology twenty percent response meaningful to patients?

Authors:  Michael M Ward; Lori C Guthrie; Maria I Alba
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

7.  Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol.

Authors:  B D Lacroix; M O Karlsson; L E Friberg
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-10-29

Review 8.  Rofecoxib for rheumatoid arthritis.

Authors:  S E Garner; D D Fidan; R R Frankish; M G Judd; T E Towheed; G Wells; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 9.  Infliximab for the treatment of rheumatoid arthritis.

Authors:  B Blumenauer; M Judd; G Wells; A Burls; A Cranney; M Hochberg; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2002

10.  A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis.

Authors:  Wei Wei; Ling-Ling Zhang; Jian-Hua Xu; Feng Xiao; Chun-De Bao; Li-Qing Ni; Xing-Fu Li; Yu-Qing Wu; Ling-Yun Sun; Rong-Hua Zhang; Bao-Liang Sun; Sheng-Qian Xu; Shang Liu; Wei Zhang; Jie Shen; Hua-Xiang Liu; Ren-Cheng Wang
Journal:  Arthritis Res Ther       Date:  2009-12-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.